INVestIgation of rheumatiC AF Treatment Using Vitamin K Antagonists, Rivaroxaban or Aspirin Studies, Superiority

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2022
This program is a comprehensive evaluation of rheumatic valvular heart disease (RVHD), Atrial fibrillation (AF)/flutter and stroke. A prospective, randomized, open-label superiority trial comparing rivaroxaban to aspirin in high risk patients either with AF and unsuitable for VKA or without AF and with high risk factors.
Epistemonikos ID: 3037b474a41248c6e9cd47adc3155aea6209f131
First added on: May 17, 2024